Europeiska unionen - svenska - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastiska medel - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Europeiska unionen - svenska - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - guanfacinhydroklorid - attention deficit disorder med hyperaktivitet - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv måste användas som en del av en omfattande adhd-behandling-program, som vanligtvis inklusive psykologiska, pedagogiska och sociala åtgärder.

Europeiska unionen - svenska - EMA (European Medicines Agency)

krka, d.d. - memantinhydroklorid - alzheimers sjukdom - andra anti-demensmedel - behandling av patienter med måttlig till svår alzheimers sjukdom.

Europeiska unionen - svenska - EMA (European Medicines Agency)

merz pharmaceuticals gmbh - memantinhydroklorid - alzheimers sjukdom - andra anti-demensmedel - behandling av patienter med måttlig till svår alzheimers sjukdom.

Europeiska unionen - svenska - EMA (European Medicines Agency)

h. lundbeck a/s - memantinhydroklorid - alzheimers sjukdom - andra anti-demensmedel - behandling av patienter med måttlig till svår alzheimers sjukdom.

Europeiska unionen - svenska - EMA (European Medicines Agency)

merz pharmaceuticals gmbh   - memantinhydroklorid - alzheimers sjukdom - andra anti-demensmedel - behandling av patienter med måttlig till svår alzheimers sjukdom.

Europeiska unionen - svenska - EMA (European Medicines Agency)

mylan pharmaceuticals limited - memantinhydroklorid - alzheimers sjukdom - other anti-dementia drugs, psychoanaleptics, - behandling av patienter med måttlig till svår alzheimers sjukdom.

Europeiska unionen - svenska - EMA (European Medicines Agency)

ratiopharm gmbh - memantinhydroklorid - alzheimers sjukdom - psychoanaleptics, - behandling av patienter med måttlig till svår alzheimers sjukdom.

Europeiska unionen - svenska - EMA (European Medicines Agency)

actavis group ptc ehf. - memantin - alzheimers sjukdom - psychoanaleptics, andra demensmediciner - behandling av patienter med måttlig till svår alzheimers sjukdom.

Europeiska unionen - svenska - EMA (European Medicines Agency)

servier (ireland) industries ltd - agomelatin - depressiv sjukdom, major - psychoanaleptics, - behandling av större depressiva episoder hos vuxna.